|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Tenascin-C Large (FN III-B) ELISA Assay | Anti-Infliximab (Remicade®, Remsima®, and Inflectra®) (ATI) ELISA | Anti-Ustekinumab (Stelara®) ELISA | Vitamin D 1,25(OH)2 ELISA Assay | Vitamin D3, 1-25-OH RIA CT Assay |
| Citations | | | | | |
| Catalog Number | 27767 | TM09003 | TM09036 | KAR1921 | KIR1929 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase sandwich ELISA for the determination of Tenascin-C high molecular weight variants including FNâ…¢-B domain in serum, EDTA Plasma, and cell culture supernatant of human, mouse and rat. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Infliximab (Remicade®, Remsima®, and Inflectra®) in serum and plasma. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Immunoenzymetric assay (ELISA) for the determination of 1,25(OH)2 Vitamin D concentrations in serum. For research use only, not for use in diagnostic procedures. | Radioimmunoassay (RIA) for the determination of human 1,25(OH)2-Vitamin D (1,25(OH)2-Vit.D) in serum and plasma. For research use only, not for use in diagnostic procedures. |
| Detection Target | CCPlus: Anti-Cyclic Citrullinated | Prolactin | sAPP Total | Leptin | Lysozyme |
| Sample Type | Serum | Serum, Blood Plasma | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum, Blood Plasma, Urine, Saliva, Breast Milk | Serum, Stool, Blood Plasma |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) |
| Detection Range | 0.20 to 12.5 ng/mL | 0 / 1 - 30 ng/mL | Anti-Ustekinumab (Stelara®) | 7.5 to 322.5 pg/mL. | 4.7 to 411 pg/mL |
| Sensitivity | 0.7 | 0.35 ng/mL | 0.06 ng/mL | 0.01 ng/mL | Inquire |
| Assay Time | 2 hrs (incubation) | 2 hours, 15 min. total incubation time. | 2 hour, 30 min. total incubation time. | 19 hrs, 25 mins (incubation) | Overnight + 15 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |